EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Standardized evaluation of Zika nucleic acid tests used in clinical settings and blood screening

Mars Stone, Sonia Bakkour, Eduard Grebe, Devy M Emperador iD, Camille Escadafal, Xutao Deng, Honey Dave, Cassandra Kelly-Cirino, Eve Lackritz, Diana P Rojas, Graham Simmons, Ingrid B Rabe und 1 weitere

PLOS Neglected Tropical Diseases · 17.03.2023 · 17 (3) · e0011157

DOI: 10.1371/journal.pntd.0011157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 17.03.2023. Verfasst von Mars Stone und 12 weiteren Autor:innen. Beteiligte Einrichtung: Vitalant Research Institute, San Francisco, California, United States of America. Hauptthemen laut MEDLINE: Zika Virus Infection, Zika Virus, Chikungunya Fever, Dengue. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early detection of Zika virus (ZIKV) transmission within geographic regions informs implementation of community mitigation measures such as vector reduction strategies, travel advisories, enhanced surveillance among pregnant women, and possible implementation of blood and organ donor screening or deferral. Standardized, comparative assessments of ZIKV assay and testing lab performance are important to develop optimal approaches to ZIKV diagnostic testing and surveillance. We conducted an expanded blinded panel study to characterize and compare the analytical performance of fifteen diagnostic and blood screening ZIKV NAT assays, including detection among single- and multiplex assays detecting ZIKV, dengue virus (DENV) and chikungunya virus (CHIKV). A 300 member blinded panel was constructed, consisting of 11 serial half-log dilutions ranging from ~10 4 to 10 −1 genome equivalents/mL in 25 replicates each of the Tahitian Asian ZIKV isolate in ZIKV-negative human serum. Additionally, clinical samples from individuals with DENV-like syndrome or suspected ZIKV infection in Brazil were evaluated. The majority of assays demonstrated good specificity. Analytical sensitivities varied 1–2 logs, with a substantially higher limit of detection (LOD) in one outlier. Similar analytical sensitivity for ZIKV RNA detection in singleplex and multiplex assays of the Grifols and ThermoFisher tests were observed. Coefficient of Assay Efficiency (CE), calculated to characterize assays’ RNA extraction and amplification efficiency, ranged from 0.13 for the Certest VIASURE multiplex and 0.75 for the Grifols multiplex assays. In general, assays using transcription mediated amplification (TMA) technology had greater CE compared to assays using conventional PCR technology. Donor screening NAT assays were significantly more sensitive than diagnostic RT-qPCR assays, primarily attributable to higher sample input volumes. However, ideal assays to maximize sensitivity and throughput may not be a viable option in all contexts, with other factors such as cost, instrumentation, and regulatory approval status influencing assay availability and selection, particularly in resource constrained settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zika Virus InfectionZika VirusChikungunya FeverDengueDengue VirusPregnancyFemaleHumansReal-Time Polymerase Chain ReactionRNA

Substanzen

RNA

Autor:innen und Institutionen

  • Vitalant Research Institute, San Francisco, California, United States of America.
  • Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, United States of America.
  • Pandemic Threats Program, FIND, Geneva, Switzerland.
  • Elizabeth Glaser Pediatric AIDS Foundation, Geneva, Switzerland.
  • World Health Organization, Geneva, Switzerland.

ORCID-Profile: Devy M Emperador

Förderung

  • World Health Organization

Zitieren

APA

Stone, M., Bakkour, S., Grebe, E., Emperador, D. M., Escadafal, C., Deng, X., Dave, H., Kelly-Cirino, C., Lackritz, E., Rojas, D. P., Simmons, G., Rabe, I. B., & Busch, M. P. (2023). Standardized evaluation of Zika nucleic acid tests used in clinical settings and blood screening. PLOS Neglected Tropical Diseases, 17(3), e0011157. https://doi.org/10.1371/journal.pntd.0011157

Vancouver

Stone M, Bakkour S, Grebe E, Emperador DM, Escadafal C, Deng X, et al. Standardized evaluation of Zika nucleic acid tests used in clinical settings and blood screening. PLOS Neglected Tropical Diseases. 2023;17(3):e0011157. doi:10.1371/journal.pntd.0011157

BibTeX
@article{Stone2023,
  author = {Stone, Mars and Bakkour, Sonia and Grebe, Eduard and Emperador, Devy M and Escadafal, Camille and Deng, Xutao and Dave, Honey and Kelly-Cirino, Cassandra and Lackritz, Eve and Rojas, Diana P and Simmons, Graham and Rabe, Ingrid B and Busch, Michael P},
  title = {Standardized evaluation of Zika nucleic acid tests used in clinical settings and blood screening},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2023},
  volume = {17},
  number = {3},
  pages = {e0011157},
  doi = {10.1371/journal.pntd.0011157}
}
Kostenlos starten →